Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P13-1+2+0+0
S65-2-4+0+0

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-01-05
ARDXArdelyx, Inc.Korner PaulEVP, Chief Medical OfficerS - Sale$12.95-6,13054,623-10%-$79,384
2017-01-20
FLXNFlexion Therapeutics IncBodick NeilChief Medical OfficerS - Sale$18.35-5,000449,620-1%-$91,747
2016-12-30
OPHTOphthotech Corp.Bolte AxelDirS - Sale$4.83-6,0000-100%-$28,980
2017-01-19
HRTXHeron Therapeutics, Inc. /de/Poyhonen JohnDirP - Purchase$12.20+10,00010,000New+$122,000
2017-01-19
HRTXHeron Therapeutics, Inc. /de/Tang Kevin CDir, 10%P - Purchase$12.20+2,459,0168,354,195+42%+$29,999,995
2017-01-20
CNABUnited Cannabis CorpVerzura TonyVP, 10%S - Sale$1.50-10,00014,291,5730%-$15,035
2017-01-20
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$8.72+8,600183,636,9560%+$74,978
2017-01-19
FGENFibrogen IncKurkijarvi KaleviDirS - Sale$24.90-2,00042,000-5%-$49,800
M
2017-01-17
CLSDClearside Biomedical, Inc.Thorp ClayDir, 10%S - Sale$8.53-68,4854,194,334-2%-$584,002
D
2017-01-18
ALDRAlder Biopharmaceuticals IncLitton Mark JamesChief Business OfficerS - Sale+OE$23.10-1,498177,932-1%-$34,599
A
2016-11-22
CRBPCorbus Pharmaceuticals Holdings, Inc.Cohen YuvalCEOP - Purchase$7.64+1,34032,830+4%+$10,238
M
2017-01-18
MRTXMirati Therapeutics, Inc.Braslyn Ltd.10%P - Purchase$5.46+61,1582,755,000+2%+$334,037
D
2017-01-18
ALNYAlnylam Pharmaceuticals, Inc.Sharp Philip ADirS - Sale+OE$37.83-15,000266,899-5%-$567,456
2017-01-20
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.28+5003,549,8520%+$140
2017-01-12
ANTBAntriabio, Inc.Welch David FDirP - Purchase$0.95+5,0001,781,4320%+$4,750
D
2017-01-18
MKubota Pharmaceutical Holdings Co LtdScheibler LukasEVP of Research, DevelopmentS - Sale+OE$8.70-1,4752,972-33%-$12,833+1
2017-01-19
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$8.75+20,000183,628,3560%+$175,038-1
D
2017-01-17
EBSEmergent Biosolutions Inc.Bailey SueDirS - Sale+OE$29.78-19,42435,818-35%-$578,4250
D
2017-01-17
EBSEmergent Biosolutions Inc.Havey AdamEVP, Biodefense DivisonS - Sale+OE$29.75-8,43834,333-20%-$251,0010
D
2017-01-17
NKTRNektar TherapeuticsRobin Howard WPres, CEOS - Sale+OE$12.35-87,500178,318-33%-$1,080,625-2
M
2017-01-17
CLSDClearside Biomedical, Inc.Hatteras Venture Advisors IV Sbic, LLCMay be part of a 13(d) Group, 10%S - Sale$8.63-29,6562,060,514-1%-$255,785-6
D
2017-01-17
ADROAduro Biotech, Inc.Brockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.86-8,00049,300-14%-$94,858+1
D
2017-01-17
PCRXPacira Pharmaceuticals, Inc.Scibetta James SPresS - Sale+OE$38.53-20,00027,084-42%-$770,698-2
D
2017-01-17
PCRXPacira Pharmaceuticals, Inc.Stack David MCEO, COBS - Sale+OE$38.41-15,00083,674-15%-$576,122-2
2017-01-18
JAZZJazz Pharmaceuticals PlcCox Russell J.EVP, COOS - Sale$128.75-4,00047,095-8%-$515,0000
M
2017-01-17
CLSDClearside Biomedical, Inc.Hatteras Venture Advisors Iii, LLCMay be part of a 13(d) Group, 10%S - Sale$8.63-25,3011,757,719-1%-$218,222-6
D
2017-01-17
DERMDermira, Inc.Griffith Christopher M.VP Corp. Dev., StrategyS - Sale+OE$29.11-1,30345,113-3%-$37,937-3
2017-01-19
RXIIRxi Pharmaceuticals CorpCauwenbergh GeertPres, CEOP - Purchase$0.69+10,00067,533+17%+$6,949-6
2017-01-17
CNABUnited Cannabis CorpVerzura TonyVP, 10%S - Sale$1.38-30,04014,301,5730%-$41,542
2017-01-18
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$8.87+10,700183,608,3560%+$94,860-3
D
2017-01-18
FPRXFive Prime Therapeutics IncSarena Francis WillardChief Strategy OfficerS - Sale+OE$47.39-3,63678,824-4%-$172,310-2
2017-01-13
KINKindred Biosciences, Inc.Park West Asset Management LLC10%P - Purchase$6.20+1,690,0003,964,138+74%+$10,478,000+3
D
2017-01-17
IONSIonis Pharmaceuticals IncBoyce SarahChief Business OfficerS - Sale+OE$46.29-1,3615,252-21%-$63,001-1
D
2017-01-17
IONSIonis Pharmaceuticals IncMonia Brett PSVP, Antisense Drug DiscoveryS - Sale+OE$46.29-2,50211,772-18%-$115,819-1
D
2017-01-17
IONSIonis Pharmaceuticals IncO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$46.29-2,24613,449-14%-$103,968-1
D
2017-01-17
IONSIonis Pharmaceuticals IncBennett C FrankSVP, Antisense ResearchS - Sale+OE$46.29-2,42114,788-14%-$112,069-1
D
2017-01-17
IONSIonis Pharmaceuticals IncCrooke Stanley TCOB, CEOS - Sale+OE$46.29-15,957766,467-2%-$738,643-1
D
2017-01-17
IONSIonis Pharmaceuticals IncParshall B LynneCOOS - Sale+OE$46.29-7,24625,651-22%-$335,414-1
D
2017-01-17
IONSIonis Pharmaceuticals IncHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$46.29-2,27310,288-18%-$105,218-1
D
2017-01-17
IONSIonis Pharmaceuticals IncGeary Richard SSVP, DevelopmentS - Sale+OE$46.29-2,44112,962-16%-$112,996-1
2017-01-17
JAZZJazz Pharmaceuticals PlcMiller Michael PatrickSVP, US CommercialS - Sale$115.93-20016,686-1%-$23,186-3
D
2017-01-17
ALKSAlkermes Plc.Ehrich ElliotEVP, R, D, CMO, Alkermes, Inc.S - Sale+OE$54.32-11,98350,657-19%-$650,9450
2017-01-13
CEMPCempra, Inc.Goldstein Dov A MdDirS - Sale$3.40-105,460150,095-41%-$358,564-2
2017-01-17
KERXKeryx Biopharmaceuticals IncAdams BrianVP, GCS - Sale$6.24-1,26599,543-1%-$7,894-6
2017-01-13
CNABUnited Cannabis CorpBlackmon EarnestPres, CEO, 10%S - Sale$1.42-30,00021,870,5790%-$42,552
DM
2017-01-10
ANTBAntriabio, Inc.Welch David FDirP - Purchase$0.93+10,0001,776,432+1%+$9,263
M
2017-01-12
MRTXMirati Therapeutics, Inc.Braslyn Ltd.10%P - Purchase$5.50+119,8872,693,842+5%+$658,855+1
2011-10-04
MRKMerck & Co., Inc.Weeks Wendell PDirS - Sale$31.35-100100-50%-$3,1350
2017-01-13
FOLDAmicus Therapeutics IncDo HungChief Science OfficerS - Sale$6.00-25,000559,266-4%-$150,0000
2017-01-13
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$9.15+15,000183,597,6560%+$137,225-2
2017-01-10
STMLStemline Therapeutics IncHoberman KennethCOOS - Sale$13.82-9,110289,190-3%-$125,900-7-19
2017-01-03
RIGLRigel Pharmaceuticals IncDuliege Anne-MarieChief Medical OfficerS - Sale$2.41-5,0005,000-50%-$12,028-7-13
D
2017-01-11
FGENFibrogen IncCotroneo PatVP, Finance, CFOS - Sale+OE$24.00-6,500132,248-5%-$156,000-70
DM
2017-01-11
FGENFibrogen IncNeff Thomas BCEO, 10%S - Sale+OE$23.85-37,7983,500,409-1%-$901,522-70
DM
2017-01-11
IRWDIronwood Pharmaceuticals IncHecht Peter MCEOS - Sale+OE$15.67-65,9874,684,872-1%-$1,034,016-4-6
D
2017-01-10
ALXNAlexion Pharmaceuticals IncBell LeonardDirS - Sale+OE$144.99-100403,6190%-$14,499-1-4
2017-01-11
ADROAduro Biotech, Inc.Templeman BlaineEVP, GCS - Sale$11.95-3,78537,300-9%-$45,231-4-10
D
2017-01-11
NERVMinerva Neurosciences, Inc.Reilly Joseph H.SVP, COOS - Sale+OE$12.03-1,6008,333-16%-$19,248-6-9
2017-01-11
REGNRegeneron Pharmaceuticals IncSanofi10%P - Purchase$369.71+87,29823,505,6940%+$32,274,872-1-2
D
2017-01-11
VRTXVertex Pharmaceuticals Inc / MaBoger Joshua SDirS - Sale+OE$82.48-8,000359,711-2%-$659,846-2-2
2017-01-13
SAGESage Therapeutics, Inc.Iguchi KimiCFO, Secretary, TreasurerS - Sale$53.92-10,00066,498-13%-$539,200+3-1
D
2017-01-10
EBSEmergent Biosolutions Inc.Abdun-Nabi DanielPres, CEOS - Sale+OE$31.28-28,240189,162-13%-$883,296+2-3
DM
2017-01-10
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$90.58-8,000353,483-2%-$724,600+10
D
2017-01-10
IONSIonis Pharmaceuticals IncCrooke Stanley TCOB, CEOS - Sale+OE$49.25-13,200752,590-2%-$650,100-3-6
2017-01-10
FGENFibrogen IncYu K PeonyChief Medical OfficerS - Sale$23.56-5,000202,448-2%-$117,800+30
2017-01-10
ACRSAclaris Therapeutics, Inc.Mehra AnandDirS - Sale$28.25-750,0001,539,480-33%-$21,188,3250-3
2017-01-11
LIXTLixte Biotechnology Holdings, Inc.Schwartzberg Gil10%P - Purchase$0.06+1,005,5569,133,539+12%+$59,328
2017-01-10
LOXOLoxo Oncology, Inc.Aisling Capital III LP10%P - Purchase$31.00+160,0004,188,920+4%+$4,960,000-30
D
2017-01-12
UTHRUnited Therapeutics CorpPatusky ChristopherDirS - Sale+OE$141.99-5,0001,300-79%-$709,969+2+4
D
2017-01-12
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$142.37-1,214640,5040%-$172,840+2+4
2017-01-10
CNABUnited Cannabis CorpRuby ChadCOOS - Sale$1.40-31,690918,760-3%-$44,449
DM
2017-01-09
VSARVersartis, Inc.Westberg PaulSVP, Corporate DevelopmentS - Sale+OE$15.67-32,50044,600-42%-$509,225-1-2
2017-01-09
ICPTIntercept Pharmaceuticals IncShapiro DavidCMO, EVP - DevelopmentS - Sale$106.01-1,56540,369-4%-$165,906+4+10
2017-01-09
KINKindred Biosciences, Inc.Park West Asset Management LLC10%P - Purchase$5.30+131,5002,274,138+6%+$696,950+1+14
2017-01-06
PFNXPfenex Inc.Signet Healthcare Partners Accredited Partnership III LP10%S - Sale$9.50-400556,6560%-$3,800-2-20
D
2017-01-09
ALKSAlkermes Plc.Cooke ShanePres, Alkermes plcS - Sale+OE$60.27-55063,944-1%-$33,149-7-7
D
2017-01-09
ALKSAlkermes Plc.Stejbach MarkSVP, Chief Comm Off, Alks IncS - Sale+OE$60.27-54734,115-2%-$32,968-7-7
D
2017-01-06
MRTXMirati Therapeutics, Inc.Braslyn Ltd.10%P - Purchase$5.60+581,8702,573,955+29%+$3,258,472-10
D
2017-01-06
MRTXMirati Therapeutics, Inc.Boxer Capital, LLC10%P - Purchase$5.60+286,163680,424+73%+$1,602,513-10
DM
2017-01-06
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$88.49-8,000353,483-2%-$707,920-5-6
2017-01-09
BMRNBiomarin Pharmaceutical IncSpiegelman Daniel KEVP, CFOS - Sale$90.00-5,00018,100-22%-$450,000-5-6
D
2017-01-09
EPZMEpizyme, Inc.Singer Andrew E.EVP, CFOS - Sale+OE$12.04-1,01333,270-3%-$12,1940-12
2017-01-09
XOMAXoma CorpNeal James RVP Business DevelopmentS - Sale$5.15-12521,325-1%-$644-3-9
2017-01-09
CNABUnited Cannabis CorpVerzura TonyVP, 10%S - Sale$1.44-18,00014,331,6130%-$25,883
2017-01-09
AQXPAquinox Pharmaceuticals, IncBaker Bros. Advisors LP10%P - Purchase$17.18+398,0629,768,979+4%+$6,836,813+1+1
DM
2017-01-05
OMEDOncomed Pharmaceuticals IncHastings Paul JCOB, CEOS - Sale+OE$8.34-42,738362,163-11%-$356,559+1-8
2017-01-06
ITEKInotek Pharmaceuticals CorpSouthwell David PPres, CEOP - Purchase$1.75+60,00062,765>999%+$105,0000+1
DM
2017-01-05
ALDRAlder Biopharmaceuticals IncLitton Mark JamesChief Business OfficerS - Sale+OE$23.01-9,516177,932-5%-$218,9920-4
2017-01-05
ITCIIntra-Cellular Therapies, Inc.Vanover Kimberly E.SVP, Clinical DevelopmentS - Sale$16.59-80010,128-7%-$13,272-1-11
2017-01-05
ITCIIntra-Cellular Therapies, Inc.Mates SharonCOB, Pres, CEOS - Sale$16.55-4,0811,088,7070%-$67,541-1-11
2017-01-05
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.VP of Finance CFOS - Sale$16.58-1,91863,389-3%-$31,800-1-11
2017-01-05
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelSVP, GCS - Sale$16.55-1,60121,506-7%-$26,497-1-11
D
2017-01-05
ALXNAlexion Pharmaceuticals IncParven Alvin SDirS - Sale+OE$138.35-22,65915,773-59%-$3,134,954-1-5
DM
2017-01-05
ALXNAlexion Pharmaceuticals IncBell LeonardDirS - Sale+OE$138.48-40,065806,904-5%-$5,548,255-1-5
M
2016-11-01
CBISCannabis Science, Inc.Tam Benjamin C.K.CFOS - Sale$0.05-10,000,0005,000,000-67%-$491,231
D
2017-01-04
IMDZImmune Design Corp.Ter Meulen Jan HenrikChief Scientific OfficerS - Sale+OE$5.35-98023,020-4%-$5,243-1+7
D
2017-01-04
IMDZImmune Design Corp.Gombotz WayneChief Development OfficerS - Sale+OE$5.35-98023,054-4%-$5,243-1+7
D
2017-01-04
IMDZImmune Design Corp.Paya Carlos VPres, CEOS - Sale+OE$5.35-3,94068,060-5%-$21,079-1+7
D
2017-01-04
IMDZImmune Design Corp.Brady Stephen REVP, Strategy, FinanceS - Sale+OE$5.35-1,64230,490-5%-$8,785-1+7
DM
2017-01-04
ALKSAlkermes Plc.Stejbach MarkSVP, Chief Comm Off, Alks IncS - Sale+OE$60.05-9,45334,115-22%-$567,6870-8

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top